RadNet Inc
SWB:PQIA

Watchlist Manager
RadNet Inc Logo
RadNet Inc
SWB:PQIA
Watchlist
Price: 43 EUR -3.59% Market Closed
Market Cap: 2.9B EUR

RadNet Inc
Investor Relations

RadNet Inc. stands as a formidable entity in the realm of diagnostic imaging services, charting its course as a crucial component within the broader healthcare sector. Founded in 1980, the company has evolved into a vital provider of outpatient imaging services across the United States, leveraging both organic growth and strategic acquisitions. RadNet operates a network of imaging centers, equipped with cutting-edge technology and staffed by experienced radiologists and technicians. These centers offer a range of diagnostic imaging procedures, including MRI, CT, mammography, X-ray, and ultrasound. By positioning itself at the intersection of healthcare efficiency and innovation, RadNet marries technology with patient care, optimizing the process of disease detection and diagnosis.

Revenue streams for RadNet primarily flow from patient payments and insurance reimbursements for services rendered. With the increasing reliance on advanced imaging techniques in modern medicine, RadNet capitalizes on the demand for accurate, timely diagnostic data from healthcare providers aiming to enhance patient care protocols. Another key revenue avenue stems from partnerships with hospitals and healthcare systems, wherein RadNet provides the technical platform and expertise, thus enabling these institutions to focus on core patient care activities. This business model not only underscores the importance of diagnostic services in preventive and restorative healthcare but also sharpens RadNet’s competitive edge through scale, efficiency, and an extensive network of service locations.

Show more
Loading

Earnings Calls

2025 Q3
Mar 6, 2025
Show Transcript
Previous
Next
GMS Inc. Reports Flat Sales Amid Market Challenges and Cost Reduction Initiatives
2025 Q3
Mar 6, 2025

In the third quarter of fiscal 2025, GMS Inc. recorded net sales of $1.3 billion, unchanged from the previous year, while organic sales declined 6.7%. A significant drop in demand, exacerbated by adverse weather and tight lending conditions, led to a gross margin reduction to 31.2%. The company is implementing $20 million in cost reductions, aiming for $50 million in yearly savings. Looking ahead, GMS anticipates a continued challenging environment, forecasting fourth-quarter net sales to decline by high single digits and adjusted EBITDA between $100 million and $110 million, with an EBITDA margin expected to reach around 8%.

Show Full Analysis

Management

Dr. Howard G. Berger M.D.
Chairman, President & CEO
No Bio Available
Mr. Mark D. Stolper
Executive VP & CFO
No Bio Available
Dr. A. Gregory Sorensen M.D.
Executive VP, Chief Science Officer & Director
No Bio Available
Mr. Norman R. Hames
President & COO of Western Operations
No Bio Available
Mr. Stephen M. Forthuber
President & COO of Eastern Operations
No Bio Available
Ms. Christine Nayoma Gordon
Senior VP of Operations of Northern California
No Bio Available
Mr. Ranjan Jayanathan
Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division
No Bio Available
Ms. Laura Foster BSRT, MPH, J.D.
Senior Vice President of Compliance & Regulatory Affairs
No Bio Available
Mr. Michael M. Murdock
Executive Vice President of Mergers & Acquisitions
No Bio Available
Mr. Derek Bomar
Senior VP & Director of Materials & Asset Management
No Bio Available

Contacts

Address
CALIFORNIA
Los Angeles
1510 Cotner Ave
Contacts
+13104787808.0
www.radnet.com